Avita Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Avita Therapeutics (RCEL) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Avita Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Avita Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Avita Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $275k | 20k | 13.72 |
| 2023-09-30 | $186k | 13k | 14.61 |
| 2023-06-30 | $297k | 18k | 17.01 |
| 2023-03-31 | $84k | 6.0k | 13.97 |
| 2022-12-31 | $4.8k | 726 | 6.60 |
| 2022-09-30 | $1.0k | 250 | 4.00 |
| 2022-06-30 | $5.1k | 1.3k | 4.00 |
| 2022-03-31 | $14k | 1.4k | 10.00 |
| 2021-12-31 | $372k | 37k | 10.00 |
| 2021-09-30 | $324k | 16k | 20.00 |
| 2021-06-30 | $24k | 1.2k | 20.00 |
| 2021-03-31 | $280k | 14k | 19.82 |
| 2020-12-31 | $37k | 1.9k | 20.00 |
| 2020-09-30 | $5.0k | 200 | 25.00 |
| 2020-06-30 | $35k | 1.2k | 30.00 |